Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1854 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 29.30 USD | -3.71% | -9.18% | -24.78% | +7.56% | 2.30 B USD | ||
| 1863 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 11.26 USD | -0.44% | -2.09% | -17.39% | +483.42% | 2.27 B USD | ||
| 1889 |  IMNM Immunome, Inc. - Common Stock | 19.31 USD | +1.10% | -9.47% | -24.83% | +31.54% | 2.19 B USD | ||
| 1894 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.22 USD | +1.31% | +1.00% | +1.57% | +35.96% | 2.16 B USD | ||
| 1899 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 29.73 USD | -1.72% | -4.59% | -14.67% | -0.03% | 2.14 B USD | ||
| 1910 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.29 USD | -1.31% | +2.09% | -1.43% | +13.56% | 2.12 B USD | ||
| 1911 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.95 USD | -7.49% | -5.50% | +25.40% | -34.60% | 2.11 B USD | ||
| 1925 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 18.34 USD | +0.33% | -4.28% | -20.64% | -18.31% | 2.08 B USD | ||
| 1931 |  VCEL Vericel Corporation - Common Stock | 40.05 USD | -1.69% | +0.10% | +3.43% | +10.18% | 2.05 B USD | ||
| 1936 |  PHVS Pharvaris N.V. - Ordinary Shares | 31.12 USD | -1.77% | -0.29% | -17.23% | +38.74% | 2.03 B USD | ||
| 1952 |  MLYS Mineralys Therapeutics, Inc. - Common Stock | 22.38 USD | +1.31% | -6.79% | -27.50% | -44.56% | 1.98 B USD | ||
| 1968 |  FTRE Fortrea Holdings Inc. - Common Stock | 20.37 USD | -0.92% | +3.19% | +24.51% | +87.74% | 1.94 B USD | ||
| 1973 |  SRPT Sarepta Therapeutics, Inc. - Common Stock | 18.21 USD | +4.06% | +2.59% | -16.51% | -21.34% | 1.92 B USD | ||
| 1982 |  AGIO Agios Pharmaceuticals, Inc. - Common Stock | 31.92 USD | +0.41% | -2.74% | -3.68% | -26.43% | 1.91 B USD | ||
| 1990 |  VIR Vir Biotechnology, Inc. - Common Stock | 11.12 USD | -3.47% | -3.72% | +0.72% | +85.95% | 1.88 B USD | ||
| 1992 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.21 USD | -2.96% | -5.38% | +5.87% | +117.17% | 1.87 B USD | ||
| 1996 |  XERS Xeris Biopharma Holdings, Inc. - Common Stock | 10.19 USD | +0.79% | +9.10% | +30.64% | +24.42% | 1.86 B USD | ||
| 2001 |  GPCR Structure Therapeutics Inc - American Depositary Shares | 25.67 USD | -3.79% | -9.29% | -37.74% | -4.00% | 1.83 B USD | ||
| 2005 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 12.83 USD | -2.36% | -11.46% | -21.86% | +28.69% | 1.83 B USD | ||
| 2008 |  XNCR Xencor, Inc. - Common Stock | 24.50 USD | +0.99% | -3.39% | -0.53% | +86.74% | 1.82 B USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |